Shingrix
Product Images NDC 50090-3372

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Shingrix (NDC 50090-3372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903372)

Shingrix vial label by A-S Medication Solutions, with NDC 50090-3372. The label identifies it as a zoster vaccine recombinant, adjuvanted, single dose of 0.5 mL. It includes storage instructions to keep refrigerated between 36 to 46 degrees Fahrenheit and not to freeze. The vial contents total 0.5 mL.*

FDA Label Image

Figure 1 (Shingrix Spl Graphic 01)

An instructional illustration showing a vial labeled as 'Adjuvant Suspension Component (liquid)' connected to a syringe with an arrow indicating the direction to pull the liquid into the syringe. This image likely demonstrates preparation steps for Shingrix vaccine administration.*

FDA Label Image

Figure 2b (Shingrix Spl Graphic 02)

An illustration showing a vial labeled with the number '2' containing lyophilized gE antigen component powder. Above it is a syringe with an arrow pointing downwards, indicating the process of adding diluent or reconstitution to the vial.*

FDA Label Image

Figure 3 (Shingrix Spl Graphic 03)

An instructional illustration showing three syringes drawing liquid from vials labeled with the number "2." Arrows indicate a left-to-right motion, suggesting the action of filling the syringes or tilting the vials for proper withdrawal of the contents.*

FDA Label Image

Figure 4 (Shingrix Spl Graphic 04)

An instructional illustration depicting the reconstitution of the Shingrix vaccine. It shows a vial labeled as the vaccine and a syringe drawing 0.5 mL from the vial, indicating the preparation step prior to administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.